Effect of taxol on cytochrome P450 3A and acetaminophen toxicity in cultured rat hepatocytes: Comparison to dexamethasone

Toxicology and Applied Pharmacology

Volumn 142, Issue 1, 1997, Pages 79-86

  Kostrubsky, Vsevolod E ^a,b   Lewis, Lionel D ^b,c   Wood, Sheryl G ^a   Sinclair, Peter R ^a,b   Wrighton, Steven A ^d   Sinclair, Jacqueline F ^a,b,e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Dept of Pharmacology/Toxicology ^*  (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d ELI LILLY AND COMPANY   (United States)

^e VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 ISOENZYME; DEXAMETHASONE; PACLITAXEL; PARACETAMOL; TROLEANDOMYCIN;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME INDUCTION; LIVER CELL CULTURE; LIVER TOXICITY; MALE; NONHUMAN; RAT;

EID: 17144464496     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.8023     Document Type: Article

References (57)

1. Birge, R., Bartolone, J., Nishanian, E., Bruno, M., Mangold, J., Cohen, S., and Khairallah, E. (1988). Dissociation of covalent binding from the oxidative effects of acetaminophen: Studies using demethylated acetaminophen derivatives. Biochem. Pharmacol. 37, 3383-3393.
2. Bruno, M. K., Cohen, S. D., and Khairallah, E. A. (1992). Selective alterations in the patterns of newly synthesized proteins by acetaminophen and its dimethylated analogues in primary cultures of mouse hepatocytes. Toxicol. Appl. Pharmacol. 112, 282-290.
3. Bulera, S., Birge, R., Cohen, S., and Khairallah, E. (1995). Identification of the mouse liver 44-kDa acetaminophen-binding protein as a subunit of glutamine synthase. Toxicol. Appl. Pharmacol. 134, 313-320.
4. Chang, T. K., Weber, G. F., Crespi, C. L., and Waxman, D. J. (1993). Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes. Cancer Res. 53, 5629-5637.
5. Chang, T. K., Gonzalez, F. J., and Waxman, D. J. (1994). Evaluation of triacetyloleandomycin, α-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes P450. Arch. Biochem. Biophys. 311, 437-442.
6. Cooper, K. O., Reik, L. M., Jayyosi, Z., Bandiera, S., Kelley, M., Ryan, D. E., Daniel, R., McCluskey, S. A., Levin, W., and Thomas, P. E. (1993). Regulation of two members of the steroid-inducible cytochrome P450 subfamily (3A) in rats. Arch. Biochem. Biophys. 301, 345-354.
7. Cresteil, T., Monsarrat, B., Alvinerie, P., Treluyer, J. M., Vieira, I., and Wright, M. (1994). Taxol metabolism by human liver microsomes: Identification of cytochrome P450 isozymes involved in its biotransformation. Cancer Res. 54, 386-392.
8. Ged, C., Rouillon, J., Pichard, L., Combalbert, J., Bressot, N., Bories, P., Michel, H., Beaune, P., and Maurel, P. (1989). The increase in urinary secretion of 6β-hydroxycortisol as a marker of human cytochrome P450I-IIA induction. Br. J. Clin. Pharmacol. 28, 373-387.
9. Gianni, L., Kearns, C., Giana, A., Vigano, L., Locatelli, A., Bonnadonna, G., and Egorin, M. (1995). Nonlinear pharmacokinetics and metabolism of taxol and its pharmacokinetic/pharmacodynamic relationships in humans. J. Clin. Oncol. 13, 180-190.
10. Gonzalez, F. J., Song, B. J., and Hardwick, J. P. (1986). Pregnenolone 16α-Carbonitrile-inducible P-450 gene family: Gene conversion and differential regulation. Mol. Cell. Biol. 6, 2969-2976.
11. Hamilton, J., Bement, W., Sinclair, J., Sinclair, P., and Wetterhahn, K. (1988). Expression of 5-aminolevulinate synthase and cytochrome P450 mRNA in chick embryo hepatocytes in vivo and in culture. Biochem. J. 255, 267-275.
12. Harris, J. W., Rahman, A., Kim, B-R., Guengerich, P., and Collins, J. M. (1994). Metabolism of Taxol by human hepatic microsomes and liver slices: Participation of cytochrome P450 3A4 and an unknown P450 enzyme. Cancer Res. 54, 4026-4035.
13. Holme, J. A., Hongslo, J. K., Bjorge, C., and Nelson, S. D. (1991). Comparative cytotoxic effect of acetaminophen (N-acetyl-p-aminophenol), a non-hepatotoxic regioisomer acetyl-m-aminophenol and their postulated reactive hydroquinone and quinone metabolites in monolayer cultures of mouse hepatocytes. Biochem. Pharmacol. 42, 1137-1142.
14. Horwitz, S. B. (1992). Mechanism of action of taxol. Trends Pharmacol. Sci. 13, 134-136.
15. Huizing, M. T., Keung, A.C., Rosing, H., Kuij, V., Huinink, W. W., Mandjes, I. M., Dubbelman, A. C., Pinedo, H. M., and Beijnen, J. H. (1993). Pharmacokinetics of taxol and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients. J. Clin. Oncol. 11, 2127-2135.
16. Hulla, J., and Juchau, M. (1989). Occurrence and inducibility of cytochrome P450IIIA in maternal and fetal rats during prenatal development. Biochemistry 28, 4871-4879.
17. Isogai, M., Shimada, N., Kamataki, T., Imaoka, S., and Funae, Y. (1993). Changes in the amounts of cytochromes P450 in rat hepatic microsomes produced by cyclosporin A. Xenobiotica 23, 799-807.
18. Jaw, S., and Jeffery, E. (1993). Interaction of caffeine with acetaminophen. Correlation of the effect of caffeine on acetaminophen hepatotoxicity and acetaminophen bioactivation following treatment of mice with various cytochrome P450 inducing agents. Biochem. Pharmacol. 46, 493-501.
19. Jollow, D., Mitchell, J., Potter, W., Davis, D., Gillette, J., and Brodie, B. (1973). Acetaminophen-induced hepatic necrosis: II. Role of covalent binding in vivo. J. Pharmacol. Exp. Ther. 187, 195-202.
20. Kocarek, T., Schuetz, E., and Guzelian, P. (1993). Expression of multiple forms of cytochrome P450 mRNAs in primary cultures of rat hepatocytes maintained on matrigel. Mol. Pharmacol. 43, 328-334.
21. Komori, M., and Oda, Y. (1994). A major glucocorticoid-inducible P450 in rat liver is not P450 3A1. J. Biochem. 116, 114-120.
22. Kostrubsky, V., Wood, S., Bush, M., Szakacs, J., Bement, J., Sinclair, P., Jeffery, E., and Sinclair, J. (1995a). Acute hepatotoxicity of acetaminophen in rats treated with ethanol plus isopentanol. Biochem. Pharmacol. 50, 1743-1748.
23. Kostrubsky, V. E., Strom, S. C., Wood, S. G., Wrighton, S. A., Sinclair, P. R., and Sinclair, J. F. (1995b). Ethanol and isopentanol increase CYP3A and CYP2E in primary cultures of human hepatocytes. Arch. Biochem. Biophys. 322, 516-520.
24. Kyle, M. E., Sakaida, I., Serrone, A., and Farber, J. (1990). Metabolism of acetaminophen by cultured rat hepatocytes. Biochem. Pharmacol. 40, 1211-1218.
25. Lee, S., Buters, J., Pineau, T., Fernandez-Salguero, P., and Gonzalez, F. (1996). Role of CYP2E1 in the hepatotoxicity of acetaminophen. J. Biol. Chem. 271, 12063-12067.
26. 3H Taxol in the nervous system of rats. Proc. Am. Soc. Clin. Oncol. 12, 160.
27. Lindenthal, J., Sinclair, J. F., Howell, S., Cargill, I., Sinclair, P. R., and Taylor, T. (1993). Toxicity of paracetamol in cultured chick hepatocytes treated with methotrexate. Eur. J. Pharmacol. 228, 289-298.
28. Louis, C. A., Wood, S. G., Kostrubsky, V. E., Sinclair, P. R., and Sinclair, J. F. (1994). Synergistic increases in rat hepatic cytochrome P450s by ethanol and isopentanol. J. Pharmacol. Exp. Ther. 269, 838-844.
29. Lowry, O., Rosebrough, N., Farr, A., and Randall, R. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
30. Madhu, C., Maziasz, T., and Klaassen, C. (1993). Effect of pregnenolone-16-α-carbonitrile and dexamethasone on acetaminophen-induced hepatotoxicity in mice. Toxicol. Appl. Pharmacol., 115, 191-198.
31. Mitchell, J., Jollow, D., Potter, W., Davis, D., Gillette, J., and Brodie, B. (1973). Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J. Pharmacol. Exp. Ther. 187, 185-194.
32. Monsarrat, B., Mariel, E., Cros, S., Gares, M., Guenard, D., Gueritte-Voegelein, F., and Wright, M. (1990). Taxol metabolism: Isolation and identification of three major metabolites of Taxol in rat bile. Drug Metab. Dispos. 18, 895-901.
33. Monsarrat, B., Alvinerie, P., Wright, M., Dubois, J., Gueritte-Voegelein, F., Guenard, D., Donehower, R. C., and Rowinsky, E. K. (1993). Hepatic metabolism and bilary excretion of Taxol in rats and humans. J. Natl. Cancer Inst. Monogr. 15, 39-46.
34. Nagata, K., Murayama, N., Miyata, M., Shimada, M., Urahasi, A., Yamazoe, Y., and Kato, R. (1996). Isolation and characterization of a new rat P450 (CYP3A-18) cDNA encoding P4506β-2 catalyzing testosterone 6β-and 16α-hydroxylations. Pharmacogenetics 6, 103-111.
35. Nelson, S. D. (1990). Molecular mechanisms of the hepatotoxicity caused by acetaminophen. Semin. Liver Dis. 10, 267-278.
36. Nims, R. W., Sinclair, P. R., Sinclair, J. F., Dragnev, K. H., Jones, C. R., Mellini, W., Thomas, P. R., and Lubet, R. A. (1993). Dose-response relationships for the induction of cytochrome P450 2B by 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene (TCPOBOP) in the rat and cultured rat hepatocytes. Xenobiotica 23, 1411-1416.
37. Patten, C. J., Thomas, P. E., Guy, R. L., Lee, M., Gonzalez, F. J., Guengerich, P. F., and Yang, C. S. (1993). Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem. Res. Toxicol. 6, 511-518.
38. Rahman, A., Korzekwa, K. R., Grogan, J., Gonzalez, F., and Harris, J. (1994). Selective biotransformation of taxol to 6α-hydroxytaxol by human cytochrome P450 2C8. Cancer Res. 54, 5543-5546.
39. Rowinsky, E. K., Onetto, N., Canetta, R. M., and Arbuck, S. G. (1992). Taxol: The first of the axanes, an important new class of antitumor agents. Semin. Oncol. 19, 646-662.
40. Rowinsky, E. K., Wright, M., Monsarrat, B., Lesser, J. J., and Donehower, R. C. (1993). Taxol: Pharmacology, metabolism and clinical implications. Cancer Surv. 17, 283-304.
41. Schiff, P. B., Fant, J., and Horwitz, S. B. (1979). Promotion of microtubule assembly in vitro by taxol. Nature (London) 277, 665-667.
42. Schuetz, E. G., Wrighton, S. A., Barwick, J. L., and Guzelian, P. S. (1984). Induction of cytochrome-P450 by glucocorticoids in rat liver. J. Biol. Chem. 259, 1999-2006.
43. Schuetz, E. G., Wrighton, S. A., Safe, S. H., and Guzelian, P. S. (1986). Regulation of cytochrome P-450p by phenobarbital and phenobarbital-like inducers in adult rat hepatocytes in primary monolayer culture and in vivo. Biochemistry 25, 1124-1133.
44. Shaw, P. M., Barnes, T. S., Cameron, D., Engeset, J., Melvin, W. T., Omar, G., Petrie, J. C., Rush, W. R., Shyder, C. P., Whiting, P. H., Wolf, C. R., and Burke, M. D. (1989). Purification and characterization of an anticonvulsant-induced human cytochrome P-450 catalysing cyclosporin metabolism. Biochem. J. 263, 653-663.
45. Sidhu, J., and Omiecinski, C. (1995). Modulation of xenobiotic-inducible cytochrome P450 gene expression by dexamethasone in primary rat hepatocytes. Pharmacogenetics 5, 24-36.
46. Sinclair, J. F., Sinclair, P. R., Smith, E. L., Bernent, W. J., Pomeroy, J., and Bonkowsky, H. (1981). Ethanol-mediated increases in cytochrome P-450 in cultured hepatocytes. Biochem. Pharmacol. 30, 2805-2809.
47. Sinclair, P., Bement, W., Haugen, S., Sinclair, J., and Guzelian, P. (1990). Induction of cytochrome P-450 and 5-aminolevulinate synthase activities in cultured rat hepatocytes. Cancer Res. 50, 5219-5224.
48. Sonnichsen, D., Liu, Q., Schuetz, E., Schuetz, J., Pappo, A., and Relling, M. J. (1995). Variability in human cytochrome P450 taxol metabolism. J. Pharmacol. Exp. Ther. 275, 566-575.
49. Spencer, C. M., and Faulds, D. (1994). Taxol, a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer. Drugs 48, 794-847.
50. Srivastava, G., Hansen, A. J., Bawden, M. J., and May, B. K. (1990). Hemin administration to rats reduces the levels of hepatic mRNAs for phenobarbitone-inducible enzymes. Mol. Pharmacol. 38, 486-493.
51. Thummel, K. E., Lee, C. A., Kunze, K. L., Nelson, S. D., and Slattery, J. T. (1993). Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4. Biochem. Pharmacol. 45, 1563-1569.
52. Walle, T., Kumar, G. N., McMillan, J. M., Thornburg, K. R., and Walle, K. U. (1993). Taxol metabolism in rat hepatocytes. Biochem. Pharmacol. 46, 1661-1664.
53. Watkins, P., Wrighton, S., Maurel, P., Schuetz, E., Mendez-Picon, G., Parker, G., and Guzelian, P. (1985). Identification of an inducible form of cytochrome P-450 in human liver. Proc. Natl. Acad. Sci. USA 82, 6310-6314.
54. Watkins, P., Murray, S., Winkelman, L., Heuman, D., Wrighton, S., and Guzelian, P. (1989). Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P450: Studies in rats and patients. J. Clin. Invest. 83, 688-697.
55. p. Biochemistry 24, 2171-2178.
56. Wrighton, S., and Stevens, J. (1992). The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev. Toxicol. 22, 1-21.
57. Zimmerman, H., and Maddrey, W. (1995). Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of the instances of therapeutic misadventure. Hepatology 22, 767-773.